Osteoarthritis new type of therapy: Invossa-K inj
Osteoarthritis is a degenerative joint disease that unfolds most frequently with age, particularly in women. It affects knees, hips, neck and lower back most commonly. People with overweight, overuse of joints (ex. athletes) or after an injury is prone to develop osteoarthritis.
This joint disease causes inflammation, stiffness and pain, thus decreasing the joint range of motion. People with this problem may have troubles doing daily activities.
Osteoarthritis common treatments
There are three common ways to treat osteoarthritis:
- Non-pharma treatment: In South Korea some acupuncture and Korean Traditional Medicine therapies are available for foreign patients. Exercise and diets can help.
- Medical drugs for pain control: NSAIDS and prescription pain killers are normal. Doctors also recommend Intra-articular corticosteroid injections and intra-articular hyaluronic acid for advanced cases.
- Surgical procedures: Joint replacement, arthroscopic debridement from the joint, osteotomy.
INVOSSA-K for knee osteoarthritis: new targeting treatment
Invossa-K inj. is the world’s first cell and gene therapy for degenerative knee osteoarthritis, approved by the Korean Ministry of Food and Drug Safety. It is potentially the first disease-modifying osteoarthritis drug (DMOAD) available in the market.
A single intra-articular injection (1 kit combining 2 solutions) has demonstrated to decrease the pain, improve the mobility and potentially stop or slow down the progression of osteoarthritis. This could a game changer for many who cannot find another solution but surgery.
Here you will find a table with key information about Invossa-K inj. osteoarthritis treatment:
|Procedure||Invossa-K inj. osteoarthritis treatment|
|Observations||Korean doctors might not recommend the procedure for ACL & medial meniscus injury. 1 to 3 days hospitalization is mandatory. All cases are subject to local doctor’s revision.|
|Total price||$9,000 – $12,500 per knee**|
Where can I find Invossa-K osteoarthritis knee treatment?
We, at Medical Avenue, have designed a fast track for foreign patients looking for Invossa-K osteoarthritis knee treatment in South Korea. It will take us 2 days from the moment we receive the client’s medical records (most recent MRI, X-rays and primary physician’s recommendations) and the Korean doctors approval for Invossa-K inj. After that, the patient can come to the hospital at their will and go through the process. The patient will stay at the hospital for 2 or 3 nights.
For more information please contact us.